Loading clinical trials...

Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT05451212

Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis

Muscle-specific tyrosine kinase (MuSK) myasthenia gravis (MG) is a rare but potentially severe disease, in which patients develop pathogenic autoantibodies that specifically target the MuSK protein in...

Lead sponsor: Cabaletta Bio•5 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

UNKNOWN

MuSK Myasthenia 1000 Study

NCT06259071 · Myasthenia Gravis, MuSK MG, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 10, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment7

Start dateNov 2022

Last updatedNov 10, 2025

Condition

MuSK Myasthenia Gravis

Locations shown

UC Irvine, Department of Neurology

Orange, California

UC Davis, Department of Neurology

Sacramento, California

University of Kansas Medical Center

Kansas City, Kansas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 10, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions